• Dhini Oktaviani
  • Amanah Amanah
  • Eni Suhaeni
  • Risnandya Primanagara


Background: Children and adults with Intellectual Disability and Autism Spectrum Disorders (ASD) have decreased intestinal permeability and enzyme activity, causing gastrointestinal (GI) problems that are more frequent and more severe than in children from the general population. The immune system which is part of the intestinal barrier in children with Intellectual Disability (ID) experiences various disorders and becomes more susceptible to fungal invasion, such as Candida spp. This present study aims to calculate the colony of Candida spp. in the digestive tract of Children with Intellectual Disability (ID) in the city of Cirebon.

Method: This is an observational study with cross-sectional design using purposive sampling. The study was conducted in November 2018-February 2019. The sample (ID) group consists of 31 individuals from Special Needs School and 60 individuals from National elementary school (non-ID) in the city of Cirebon. The inclusion criteria were children ages 6-12 years and the exclusion criteria were children under antifungal treatment and children under cytotoxic or immunosuppressive drugs.  The fecal samples from the ID group and non-ID were examined at the Laboratory of the Faculty of Medicine, Universitas Swadaya Gunung Jati Cirebon, Indonesia using Digital Colony counter. Collected data were stored and analyzed using computer aided Statistical program. Mann-Whitney analysis of variance techniques were used to test the hypotheses.

Results: The results showed that there are significant differences in the colonies of Candida spp. between the ID group and non-ID group. Median colony of Candida spp. in the ID group is 39.00 with mean colony of 126.90 while the median colony of non-ID group is 3.00 with mean colony of 40.93 (p<0.001).

Conclusion: There are significant differences between the Candida spp. colonies in the ID group with the non-ID.


Mefford HC, Batshaw ML, Hoffman EP. Genomics, intellectual disability and autism. N Engl J Med. 2012;366:733–743.

Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism–comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011;16:11–22.

Puri RD, Tuteja M, Verma IC. Genetic Approach to Diagnosis of Intellectual Disability. 2016;83(10):1141-9.

Kementrian Pendidikan dan Kebudayaan Pusat Data dan Statistik Pendidikan dan Kebudayaan Statistik. Sekolah Luar Biasa 2016-2017. Indonesia. 2017

Anna Strunecka, Russell L. Blaylock, Mark A. Hyman and Ivo Paclt. Cellular and Molecular Biology of Autism Spectrum Disorders. Charles University in Prague Czech Republic. 2010;82:217.

Bolte, E. R.. Autism and Clostridium tetani. Med Hypotheses. 2011; 51,133–144.

Knivsberg, A. M., Reichelt, K. L., Hoien, Tamp; Nodland, M. A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci. 2008; 5, 251–261.

Fugelsang K., Edwards C., Wine Microbiology Second Edition pgs 3-28 Springer Science and Business Media, New York; 2010

Brown Rosk, Lozupune Catherine, ETC. Gut Bacteria in children withs autism spectrum disorder challenges and promise of studying how a complex community influences a complex disease. Journal Microbial ecology in health & disease. 2015; 26;26914

Reichelt K, Knivsberg A. The possibility and probability of a gut-to-brain connection in autism.AmClin Psychiatry. 2009;21:205–11.

Bernard R., (1988): Autism Research Institute, 4182Adams Avenue, San Diego, CA 92116, First published in 1988.

Emam AM, Esmat Mamdouh, and Sadek Abdelharim A. Candida albicans infection in Autism, Journal of American Science. 2012;8:12.

Gupta S. Immunology and immunologic treatment of Autism. Proceeding of the National Autism Assn,. 1996;2:455-60.

Wang L. W. Tancredi D. The prevalence of Gastrointestinal problems in children across the united states with Autism Spectrum Disorder from families with multiple affected members. J. Dev. 2011;32, 351-360.

R. Herawati, I. Parwati, I. Sjahid, C. Rita. Hitung koloni Candida albicans di tinja anak gangguan autism spectrum. (Colony Count Candida Albicans of Stool in Autism Spectrum Disorders) Indonesian Journal of Clinical Pathology and Medical Laboratory. 2006;13(1) 4-8

Knivsberg, A. M., Reichelt, K. L., Hoien, Tamp; Nodland, M. A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci. 2008; 5, 251–261.

Hoffman C., Dollive S., Grunberg S., Chen J., Li H. Archaea and Fungi of the human gut microbiome:Correlations with diet and bacterial resident. 2013; 17;8(6)

M. De Angelis, M. Piccolo, L. Vannini, S. Siragusa, A. De Giacomo, D.I. Serrazzanetti, et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. 2013; 9;8(10).

S. Gabriele, R. Sacco, S. Cerullo, C. Neri, A. Urbani, G. Tripi, et al. Urinary p-cresol is elevated in young French children with autism spectrum disorder: a replication study. Biomarkers. 2014; 19 ;463-70.

Gomez, A., Luckey, D., & Taneja, V. The gut microbiome in autoimmunity: Sex matters. Journal of Clinical Immunology. 2015;159, 154–162.

Raymond FL. X-linked mental retardation guide : a clinical guide. J. Med. Genet. 2006;43;193-200.

Klotz, S. A., Chasin, B. S., Powell, B., Gaur, N. K. & Lipke, P. N. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis. 2007; 59, 401–406.

Rizzetto L, Weil T, Cavalieri D. Systems level dissection of Candida recognition by Dectins: a matter of fungal morphology and site of infection. Pathogens. 2015; 4:639–61.

Shankarkumar. U. The Human Leukocyte Antigen (HLA) System. HLA Department, Institute of Immunohaematology. Int J Hum Genet. 2004;4(2): 91-103.